| Year |
Citation |
Score |
| 2023 |
Pavlick AC, Ariyan CE, Buchbinder EI, Davar D, Gibney GT, Hamid O, Hieken TJ, Izar B, Johnson DB, Kulkarni RP, Luke JJ, Mitchell TC, Mooradian MJ, Rubin KM, Salama AK, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. Journal For Immunotherapy of Cancer. 11. PMID 37852736 DOI: 10.1136/jitc-2023-006947 |
0.339 |
|
| 2020 |
Hu Y, Briggs A, Gennarelli RL, Bartlett EK, Ariyan CE, Coit DG, Brady MS. Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost. Annals of Surgical Oncology. PMID 32514805 DOI: 10.1245/S10434-020-08558-8 |
0.333 |
|
| 2020 |
Bartlett EK, Lee AY, Spanheimer PM, Bello DM, Brady MS, Ariyan CE, Coit DG. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. The British Journal of Surgery. PMID 32484242 DOI: 10.1002/Bjs.11621 |
0.382 |
|
| 2020 |
Kelly CM, Antonescu CR, Bowler T, Munhoz R, Chi P, Dickson MA, Gounder MM, Keohan ML, Movva S, Dholakia R, Ahmad H, Biniakewitz M, Condy M, Phelan H, Callahan M, ... ... Ariyan C, et al. Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial. Jama Oncology. PMID 31971541 DOI: 10.1001/Jamaoncol.2019.6152 |
0.384 |
|
| 2019 |
Bello DM, Panageas KS, Hollmann T, Shoushtari AN, Momtaz P, Chapman PB, Postow MA, Callahan MK, Wolchok JD, Brady MS, Coit DG, Ariyan CE. Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade. Annals of Surgical Oncology. PMID 31848819 DOI: 10.1245/S10434-019-08099-9 |
0.377 |
|
| 2019 |
Bartlett EK, Flynn JR, Panageas KS, Ferraro RA, Sta Cruz JM, Postow MA, Coit DG, Ariyan CE. High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy. Cancer. PMID 31584709 DOI: 10.1002/Cncr.32506 |
0.362 |
|
| 2019 |
Perez MC, Zager JS, Amatruda T, Conry R, Ariyan C, Desai A, Kirkwood JM, Treichel S, Cohan D, Raskin L. Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1). Melanoma Management. 6: MMT19. PMID 31406563 DOI: 10.2217/Mmt-2019-0012 |
0.306 |
|
| 2019 |
Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, et al. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. The Lancet. Oncology. 20: e378-e389. PMID 31267972 DOI: 10.1016/S1470-2045(19)30332-8 |
0.385 |
|
| 2019 |
Navarrete-Dechent C, Aleissa S, Ariyan C, Busam KJ, Nehal KS. Comment on "Comparison of surgical margins for lentigo maligna versus melanoma in situ". Journal of the American Academy of Dermatology. 81. PMID 31233855 DOI: 10.1016/J.Jaad.2019.05.104 |
0.321 |
|
| 2019 |
Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, ... ... Ariyan CE, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature Genetics. PMID 30643254 DOI: 10.1038/S41588-018-0312-8 |
0.36 |
|
| 2019 |
Perez M, Amatruda T, Conry RM, Ariyan CE, Desai AM, Kirkwood JM, Treichel S, Ismail R, Raskin L. Checkpoint inhibitor (CPI) experienced patients (pts) from COSMUS-1: A clinical observational study of talimogene laherparepvec (T-VEC) in United States practice. Journal of Clinical Oncology. 37: 142-142. DOI: 10.1200/Jco.2019.37.8_Suppl.142 |
0.318 |
|
| 2019 |
Shoushtari AN, Sanchez-Vega F, Kantheti H, Callahan MK, Postow MA, Barker CA, Chatila WK, Jonsson P, Ariyan CE, Brady MS, Coit DG, Nair S, Chapman PB, Busam KJ, Solit DB, et al. Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas. Journal of Clinical Oncology. 37: 9539-9539. DOI: 10.1200/Jco.2019.37.15_Suppl.9539 |
0.301 |
|
| 2019 |
Raj NP, Zheng Y, Kelly V, Katz S, Chou JF, Do RKG, Capanu M, Zamarin D, Ariyan CE, Untch BR, O'Reilly EM, Gopalan A, Berger MF, Olino K, Segal NH, et al. Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma. Journal of Clinical Oncology. 37: 4112-4112. DOI: 10.1200/Jco.2019.37.15_Suppl.4112 |
0.32 |
|
| 2019 |
Kelly CM, Chi P, Dickson MA, Gounder MM, Keohan ML, Qin L, Adamson T, Condy MM, Biniakewitz M, Phelan H, Singer S, Crago AM, Yoon SS, Ariyan CE, Hwang S, et al. A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma. Journal of Clinical Oncology. 37: 11049-11049. DOI: 10.1200/Jco.2019.37.15_Suppl.11049 |
0.387 |
|
| 2018 |
Zhang M, Di Martino JS, Bowman RL, Campbell NR, Baksh SC, Simon-Vermot T, Kim IS, Haldeman P, Mondal C, Yong-Gonzalez V, Abu-Akeel M, Merghoub T, Jones DR, Zhu XG, Arora A, ... Ariyan CE, et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discovery. PMID 29903879 DOI: 10.1158/2159-8290.Cd-17-1371 |
0.328 |
|
| 2018 |
Lezcano C, Shoushtari AN, Ariyan C, Hollmann TJ, Busam KJ. Primary and Metastatic Melanoma With NTRK Fusions. The American Journal of Surgical Pathology. PMID 29683819 DOI: 10.1097/Pas.0000000000001070 |
0.36 |
|
| 2018 |
Ariyan CE, Brady MS, Siegelbaum RH, Hu J, Bello DM, Green J, Fisher C, Lefkowitz RA, Panageas KS, Pulitzer M, Vignali M, Emerson R, Tipton C, Robins H, Merghoub T, et al. Robust antitumor responses result from local chemotherapy and CTLA-4 blockade. Cancer Immunology Research. PMID 29339377 DOI: 10.1158/2326-6066.Cir-17-0356 |
0.38 |
|
| 2018 |
Shoushtari AN, Armenia J, Arora A, Rojas-Zamalloa J, Warner AB, Derr M, Postow MA, Callahan MK, Momtaz P, Coit DG, Brady MS, Ariyan CE, Nair S, Busam KJ, Chapman PB, et al. Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma. Journal of Clinical Oncology. 36: 9561-9561. DOI: 10.1200/Jco.2018.36.15_Suppl.9561 |
0.344 |
|
| 2018 |
Kelly CM, Bowler TG, Munhoz RR, Chi P, Dickson MA, Gounder MM, Keohan ML, Dholakia R, Condy MM, Singer S, Crago AM, Yoon SS, Ariyan CE, Hwang S, Erinjeri JP, et al. A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma. Journal of Clinical Oncology. 36: 11516-11516. DOI: 10.1200/Jco.2018.36.15_Suppl.11516 |
0.308 |
|
| 2017 |
Momtaz P, Harding JJ, Ariyan C, Coit DG, Merghoub T, Gasmi B, You D, Viale A, Panageas KS, Samoila A, Postow MA, Wolchok JD, Chapman PB. Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation. Oncotarget. 8: 105000-105010. PMID 29285228 DOI: 10.18632/Oncotarget.21072 |
0.331 |
|
| 2017 |
Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Annals of Surgical Oncology. PMID 29236202 DOI: 10.1245/S10434-017-6267-7 |
0.333 |
|
| 2017 |
Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017757724. PMID 29232171 DOI: 10.1200/Jco.2017.75.7724 |
0.391 |
|
| 2017 |
Herbert G, Karakousis GC, Bartlett EK, Zaheer S, Graham D, Czerniecki BJ, Fraker DL, Ariyan C, Coit DG, Brady MS. Transected thin melanoma: Implications for sentinel lymph node staging. Journal of Surgical Oncology. PMID 29194673 DOI: 10.1002/Jso.24930 |
0.359 |
|
| 2017 |
Karakousis G, Ariyan C. An Update on Randomized Clinical Trials in Melanoma. Surgical Oncology Clinics of North America. 26: 559-586. PMID 28923220 DOI: 10.1016/J.Soc.2017.05.002 |
0.314 |
|
| 2017 |
Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z, Halperin RF, Helland A, Nasser S, Legendre C, Hurley LH, ... ... Ariyan CE, et al. Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Research. 27: 524-532. PMID 28373299 DOI: 10.1101/Gr.213348.116 |
0.332 |
|
| 2017 |
Cassidy MR, Wolchok RE, Zheng J, Panageas KS, Wolchok JD, Coit D, Postow MA, Ariyan C. Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment. Ebiomedicine. PMID 28356222 DOI: 10.1016/J.Ebiom.2017.03.029 |
0.373 |
|
| 2017 |
Davis JL, Langan RC, Panageas KS, Zheng J, Postow MA, Brady MS, Ariyan C, Coit DG. Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma. Annals of Surgical Oncology. PMID 28303429 DOI: 10.1245/S10434-017-5836-0 |
0.348 |
|
| 2017 |
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Grotz TE, Allred JB, Suman VJ, Brady MS, et al. Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial. Annals of Surgery. 265: 192-196. PMID 28009745 DOI: 10.1097/Sla.0000000000001670 |
0.365 |
|
| 2016 |
Lee AY, Droppelmann N, Panageas KS, Zhou Q, Ariyan CE, Brady MS, Chapman PB, Coit DG. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients. Annals of Surgical Oncology. PMID 27804026 DOI: 10.1245/S10434-016-5642-0 |
0.319 |
|
| 2016 |
Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD, Carvajal RD, Postow MA. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis. The Oncologist. PMID 27286787 DOI: 10.1634/Theoncologist.2015-0522 |
0.4 |
|
| 2016 |
Ariyan C. Complete lymph node dissection in melanoma. Lancet Oncology. 17: 688-689. PMID 27161538 DOI: 10.1016/S1470-2045(16)30071-7 |
0.328 |
|
| 2016 |
Cassidy MR, Wolchok R, Zheng J, Panageas K, Wolchok JD, Coit DG, Postow MA, Ariyan CE. Neutrophil to lymphocyte ratio to predict outcome during ipilimumab treatment. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E21008 |
0.375 |
|
| 2016 |
Bello DM, Callahan MK, Busam K, Ariyan CE. Appendiceal Enlargement During Immunotherapy Treatment for Melanoma Clinical Skin Cancer. 1: 106-109. DOI: 10.1016/J.Clsc.2017.07.002 |
0.322 |
|
| 2015 |
Johnson DB, Peng C, Abramson RG, Ye F, Zhao S, Wolchok JD, Sosman JA, Carvajal RD, Ariyan CE. Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review. The Oncologist. 20: 648-52. PMID 25964307 DOI: 10.1634/Theoncologist.2014-0468 |
0.372 |
|
| 2015 |
Green J, Ariyan C. Update on immunotherapy in melanoma. Surgical Oncology Clinics of North America. 24: 337-46. PMID 25769716 DOI: 10.1016/J.Soc.2014.12.010 |
0.337 |
|
| 2014 |
Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin. Annals of Surgical Oncology. 21: 4324-9. PMID 24962937 DOI: 10.1245/S10434-014-3845-9 |
0.355 |
|
| 2014 |
Gill K, Ariyan C, Wang X, Brady MS, Pulitzer M. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression. Journal of Surgical Oncology. 110: 258-64. PMID 24891295 DOI: 10.1002/Jso.23636 |
0.33 |
|
| 2014 |
Frankel TL, Bamboat ZM, Ariyan C, Coit D, Sabel MS, Brady MS. Predicting the development of brain metastases in patients with local/regional melanoma. Journal of Surgical Oncology. 109: 770-4. PMID 24862924 DOI: 10.1002/Jso.23574 |
0.307 |
|
| 2014 |
Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG. Observation after a positive sentinel lymph node biopsy in patients with melanoma. Annals of Surgical Oncology. 21: 3117-23. PMID 24833100 DOI: 10.1200/Jco.2013.31.15_Suppl.9033 |
0.414 |
|
| 2014 |
Bello DM, Dematteo RP, Ariyan CE. The GIST of targeted therapy for malignant melanoma. Annals of Surgical Oncology. 21: 2059-67. PMID 24531699 DOI: 10.1245/S10434-013-3373-Z |
0.344 |
|
| 2014 |
Steinman J, Ariyan C, Rafferty B, Brady MS. Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion. Journal of Surgical Oncology. 109: 405-9. PMID 24318953 DOI: 10.1002/Jso.23519 |
0.387 |
|
| 2014 |
Ariyan CE, Lefkowitz RA, Panageas K, Callahan MK, Misholy O, Bello D, Fisher C, Kotin A, Siegelbaum R, Coit DG, Wolchok JD, Brady MS. Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma. Journal of Clinical Oncology. 32: 9078-9078. DOI: 10.1200/Jco.2014.32.15_Suppl.9078 |
0.345 |
|
| 2014 |
Johnson DB, Peng C, Abramson RG, Wolchok JD, Sosman JA, Carvajal RD, Ariyan CE. Ipilimumab in acral melanoma: A retrospective review. Journal of Clinical Oncology. 32: 9056-9056. DOI: 10.1200/Jco.2014.32.15_Suppl.9056 |
0.417 |
|
| 2014 |
Bello D, Allison J, Ariyan C. B7H3 Expression Correlates with Reduced Infiltration of T cells in Melanoma Tumors and Poor Survival Outcomes Journal of Surgical Research. 186: 564-565. DOI: 10.1016/J.Jss.2013.11.488 |
0.355 |
|
| 2013 |
Gyorki DE, Callahan M, Wolchok JD, Ariyan CE. The delicate balance of melanoma immunotherapy. Clinical & Translational Immunology. 2: e5. PMID 25505953 DOI: 10.1038/Cti.2013.5 |
0.302 |
|
| 2013 |
Bello DM, Ariyan CE, Carvajal RD. Melanoma mutagenesis and aberrant cell signaling. Cancer Control : Journal of the Moffitt Cancer Center. 20: 261-81. PMID 24077403 DOI: 10.1177/107327481302000404 |
0.326 |
|
| 2013 |
Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Annals of Surgical Oncology. 20: 3618-25. PMID 23838913 DOI: 10.1245/S10434-013-3089-0 |
0.406 |
|
| 2013 |
Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, Burke MM, Caldwell A, Kronenberg SA, Agunwamba BU, Zhang X, et al. Nivolumab plus ipilimumab in advanced melanoma. The New England Journal of Medicine. 369: 122-33. PMID 23724867 DOI: 10.1056/Nejmoa1302369 |
0.378 |
|
| 2013 |
Gyorki DE, Yuan J, Mu Z, Zaidi B, Pulitzer M, Busam K, Brady MS, Coit DG, Allison JP, Wolchok JD, Ariyan CE. Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma. Annals of Surgical Oncology. 20: 3106-11. PMID 23681603 DOI: 10.1245/S10434-013-2999-1 |
0.353 |
|
| 2013 |
Perez DR, Trakarnsanga A, Shia J, Nash GM, Temple LK, Paty PB, Guillem JG, Garcia-Aguilar J, Bello D, Ariyan C, Carvajal RD, Weiser MR. Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Annals of Surgical Oncology. 20: 2339-44. PMID 23328972 DOI: 10.1245/S10434-012-2812-6 |
0.392 |
|
| 2013 |
Bello DM, Smyth E, Perez D, Khan S, Temple LK, Ariyan CE, Weiser MR, Carvajal RD. Anal versus rectal melanoma: does site of origin predict outcome? Diseases of the Colon and Rectum. 56: 150-7. PMID 23303142 DOI: 10.1097/Dcr.0B013E31827901Dd |
0.312 |
|
| 2013 |
Karakousis GC, Pandit-Taskar N, Hsu M, Panageas K, Atherton S, Ariyan C, Brady MS. Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma Research. 23: 40-6. PMID 23250048 DOI: 10.1097/Cmr.0B013E32835D5062 |
0.392 |
|
| 2013 |
Schindler K, Harmankaya K, Postow MA, Frantal S, Bello D, Ariyan CE, Michielin OA, Hoeller C, Pehamberger H, Wolchok JD. Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody. Journal of Clinical Oncology. 31: 9024-9024. DOI: 10.1200/Jco.2013.31.15_Suppl.9024 |
0.401 |
|
| 2013 |
Callahan MK, Horak CE, Curran MA, Hollman T, Schaer DA, Yuan J, Lesokhin AM, Kitano S, Hong Q, Ariyan CE, Busam KJ, Feely W, Jure-Kunkel M, Grosso J, Simon JS, et al. Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab. Journal of Clinical Oncology. 31: 3003-3003. DOI: 10.1200/Jco.2013.31.15_Suppl.3003 |
0.325 |
|
| 2013 |
Callahan MK, Horak CE, Curran MA, Hollman T, Schaer DA, Yuan J, Lesokhin AM, Kitano S, Hong Q, Ariyan CE, Busam KJ, Feely W, Jure-Kunkel M, Grosso J, Simon JS, et al. Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-O6 |
0.319 |
|
| 2012 |
Plitas G, Ariyan CE. Controversies in the management of regional nodes in melanoma. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 414-21. PMID 22393199 DOI: 10.6004/Jnccn.2012.0038 |
0.364 |
|
| 2012 |
Gyorki DE, Yuan J, Mu Z, Zaidi B, Gallardo HF, Brady MS, Gutin PH, Coit DG, Wolchok JD, Ariyan CE. Surgery for patients receiving ipilimumab: Safety profile and immunological insights. Journal of Clinical Oncology. 30: 8583-8583. DOI: 10.1200/Jco.2012.30.15_Suppl.8583 |
0.38 |
|
| 2011 |
Balachandran VP, Cavnar MJ, Zeng S, Bamboat ZM, Ocuin LM, Obaid H, Sorenson EC, Popow R, Ariyan C, Rossi F, Besmer P, Guo T, Antonescu CR, Taguchi T, Yuan J, et al. Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nature Medicine. 17: 1094-100. PMID 21873989 DOI: 10.1038/Nm.2438 |
0.347 |
|
| 2011 |
Ariyan CE, Quezada S, Corse E, Montalvo W, Allison J. Abstract 1786: Improved survival with gemcitabine and CTLA-4 blockade in a murine model of prostate cancer Cancer Research. 71: 1786-1786. DOI: 10.1158/1538-7445.Am2011-1786 |
0.361 |
|
| 2010 |
Busam KJ, Ariyan C, Coit DC. Desmoplastic melanoma in African American patients. Archives of Dermatology. 146: 796-797. PMID 20644048 DOI: 10.1001/Archdermatol.2010.149 |
0.313 |
|
| 2010 |
Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Annals of Surgical Oncology. 17: 514-20. PMID 19924486 DOI: 10.1245/S10434-009-0836-3 |
0.354 |
|
| 2010 |
Kingham TP, Karakousis G, Ariyan C. Randomized clinical trials in melanoma. Surgical Oncology Clinics of North America. 19: 13-31. PMID 19914558 DOI: 10.1016/J.Soc.2009.09.008 |
0.386 |
|
| 2009 |
Ariyan C, Brady MS, Gönen M, Busam K, Coit D. Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma Annals of Surgical Oncology. 16: 186-190. PMID 18979135 DOI: 10.1245/S10434-008-0187-5 |
0.406 |
|
| 2008 |
Ariyan CE, Coit DG. Clinical aspects of sentinel lymph node biopsy in melanoma. Seminars in Diagnostic Pathology. 25: 86-94. PMID 18697711 DOI: 10.1053/J.Semdp.2008.04.004 |
0.409 |
|
| 2008 |
Ariyan CE, Brady MS. History of regional chemotherapy for cancer of the extremities. International Journal of Hyperthermia. 24: 185-192. PMID 18392997 DOI: 10.1080/02656730701785102 |
0.38 |
|
| 2007 |
Ariyan C, Strong VE. The Current Status of Laparoscopic Adrenalectomy Advances in Surgery. 41: 133-153. PMID 17972561 DOI: 10.1016/J.Yasu.2007.05.008 |
0.301 |
|
| 2006 |
Viola KV, Ariyan C, Sosa JA. Surgical perspectives in gastrointestinal disease: a study of quality of life outcomes in esophageal, pancreatic, colon, and rectal cancers. World Journal of Gastroenterology. 12: 3213-3218. PMID 16718841 DOI: 10.3748/Wjg.V12.I20.3213 |
0.322 |
|
| 2004 |
Ariyan S, Ariyan C, Farber LR, Fischer DS, Flynn SD, Truini C. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. Journal of the American College of Surgeons. 198: 924-32. PMID 15194074 DOI: 10.1016/J.Jamcollsurg.2004.01.034 |
0.38 |
|
| Show low-probability matches. |